Stocks and Investing
Stocks and Investing
Mon, November 6, 2023
[ Mon, Nov 06th 2023
] - WOPRAI
[ Mon, Nov 06th 2023
] - WOPRAI
[ Mon, Nov 06th 2023
] - WOPRAI
[ Mon, Nov 06th 2023
] - WOPRAI
[ Mon, Nov 06th 2023
] - WOPRAI
[ Mon, Nov 06th 2023
] - WOPRAI
[ Mon, Nov 06th 2023
] - WOPRAI
[ Mon, Nov 06th 2023
] - WOPRAI
Sun, November 5, 2023
[ Sun, Nov 05th 2023
] - WOPRAI
Fri, November 3, 2023
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
[ Fri, Nov 03rd 2023
] - WOPRAI
Michael Ulz Maintained (ALNY) at Hold with Increased Target to $183 on, Nov 3rd, 2023
Michael Ulz of Morgan Stanley, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold with Increased Target from $175 to $183 on, Nov 3rd, 2023.
Michael has made no other calls on ALNY in the last 4 months.
There are 9 other peers that have a rating on ALNY. Out of the 9 peers that are also analyzing ALNY, 2 agree with Michael's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Olivia Brayer of "Cantor Fitzgerald" Maintained at Hold with Decreased Target to $170 on, Monday, October 16th, 2023
- Leland Gershell of "Oppenheimer" Downgraded from Buy to Hold on, Wednesday, October 11th, 2023
These are the ratings of the 7 analyists that currently disagree with Michael
- Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $395 on, Wednesday, October 11th, 2023
- Kostas Biliouris of "BMO Capital" Maintained at Buy with Decreased Target to $234 on, Tuesday, October 10th, 2023
- David Lebovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $233 on, Tuesday, October 10th, 2023
- Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $200 on, Monday, October 9th, 2023
- Gary Nachman of "Raymond James" Initiated at Buy and Held Target at $208 on, Friday, September 29th, 2023
- Paul Matteis of "Stifel" Reiterated at Strong Buy and Held Target at $240 on, Thursday, September 14th, 2023
- Keay Nakae of "Chardan Capital" Reiterated at Strong Buy and Held Target at $250 on, Tuesday, August 8th, 2023
Contributing Sources